Dynapenia and quality of life in HIV-infected individuals
DOI:
https://doi.org/10.5935/0104-7795.20170034Keywords:
HIV Seropositivity, Muscle Weakness, Quality of LifeAbstract
The appearance of effective antiretroviral therapy (ART) has transformed the evolutionary profile of acquired human immunodeficiency virus (HIV) into a chronic disease, with increased life expectancy but complications related to its use, such as muscle weakness. Objective: Describe the occurrence of dynapenia and its relationship with quality of life in HIV infected individuals. Methods: This is a cross-sectional observational study, in which handgrip strength was evaluated with handgrip dynamometry. HIV-infected individuals aged ≥18 years and ability to have muscle strength measured were included. The diagnosis of dynapenia was determined by the literature for handgrip strength evaluation and body mass index (BMI). Short-Form Health Survey (SF-36) was used to evaluate the quality of life, and other variables such as time to use ART and the Charlson Comorbidity Index (CCI), as well as age, gender and weight were recorded. Results: The presence of dynapenia was 11.6% in the sample studied. There was an association of dynapenia with the variables age (p = 0.0001), presence of cormobities (p = 0.0001), lower handgrip strength (p = 0.0001) and lower BMI (p = 0.033). The quality of life has been compromised in both the physical and mental domains. Conclusion: There is dynapenia in part of the individuals with HIV and its association with poorer quality of life was found, what suggests the necessity of screening and treatment of this often underreported health problem in this population.
Downloads
References
Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve. 2005;32(3):247-60. DOI: http://dx.doi.org/10.1002/mus.20338
Ippolito G, Galati V, Serraino D, Girardi E. The changing picture of the HIV/AIDS epidemic. Ann N Y Acad Sci. 2001;946:1-12. DOI: http://dx.doi.org/10.1111/j.1749-6632.2001.tb03899.x
A ONU e a resposta à AIDS no Brasil. Brasília: UNAIDS; 2013.
Authier FJ, Gherardi RK. Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy. Rev Neurol (Paris). 2006;162(1):71-81.
Patil R, Shimpi A, Rairikar S, Shyam A, Sancheti P. Effects of fitness training on physical fitness parameters and quality of life in human immunodeficiency virus-positive Indian females. Indian J Sex Transm Dis. 2017;38(1):47-53. DOI: http://dx.doi.org/10.4103/0253-7184.196886
Dudgeon WD, Phillips KD, Carson JA, Brewer RB, Durstine JL, Hand GA. Counteracting muscle wasting in HIV-infected individuals. HIV Med. 2006;7(5):299-310. DOI: http://dx.doi.org/10.1111/j.1468-1293.2006.00380.x
Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;11(3):260. DOI: http://dx.doi.org/10.3389/fphys.2012.00260
Roubenoff R. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am J Manag Care. 2000;6(9):1003-16.
Chariot P, Bignani O. Skeletal muscle disorders associated with selenium deficiency in humans. Muscle Nerve. 2003 Jun;27(6):662-8.
Melchior R, Nemes MIB, Alencar TM, Buchalla CM. Desafios da adesão ao Tratamento de pessoas vivendo com HIV / Aids no Brasil. Rev Saúde Pública 2007; 41 (Supl. 2): 87-93.
De Carvalho BF, Policarpo S, Moreira AC. Nutritional status and quality of life in HIV-infected patients. Nutr Hosp.2017; 34(4):923-33.
Wasserman P, Segal-Maurer S, Rubin SD. High prevalence of low skeletal muscle mass associated with male gender in midlife and older HIV-infected persons despite CD4 cell reconstitution and viral suppression. J Int Assoc Provid AIDS Care. 2014;13(2):145-52. DOI: http://dx.doi.org/10.1177/2325957413495919
Campolina AG, Bortoluzzo AB, Ferraz MB, Ciconelli RM. Validation of the Brazilian version of the generic six-dimensional short form quality of life questionnaire (SF-6D Brazil). Cien Saude Colet. 2011;16(7):3103-10. DOI: http://dx.doi.org/10.1590/S1413-81232011000800010
Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF36 (Brasil SF-36). Rev Bras Reumatol. 1999; 39(3):143-50.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. DOI: http://dx.doi.org/10.1016/0021-9681(87)90171-8
Lédo APO, Neves JS, Martinez BP, Neto MG, Brites C. Sarcopenia em uma amostra de indivíduos infectados HIV atendidos a nível ambulatorial. Rev Pesq Fisioter. 2017;7(3):351-358.
Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67(1):28-40.
Raso V, Shephard RJ, Rosário Casseb JS, Silva Duarte AJ, D'Andréa Greve JM. Handgrip force offers a measure of physical function in individuals living with HIV/AIDS. J Acquir Immune Defic Syndr. 2013;63(1):e30-2.
Oliveira VH, Wiechmann SL, Narciso AM, Webel AR, Deminice R. Muscle strength is impaired in men but not in women living with HIV taking antiretroviral therapy. Antivir Ther. 2018;23(1):11-19. DOI: http://dx.doi.org/10.3851/IMP3159
Erlandson KM1, Schrack JA, Jankowski CM, Brown TT, Campbell TB. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep. 2014;11(3):279-90. DOI: http://dx.doi.org/10.1007/s11904-014-0215-y
HIV Neuromuscular Syndrome Study Group. HIV-associated neuromuscular weakness syndrome. AIDS. 2004;18(10):1403-12. DOI: http://dx.doi.org/10.1097/01.aids.0000131309.70451.fe
Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy. Ann Neurol. 1993;34(2):206-11. DOI: http://dx.doi.org/10.1002/ana.410340217
Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991;337(8740):508-10. DOI: http://dx.doi.org/10.1016/0140-6736(91)91294-5
Currier JS, Havlir DV. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2009;17(2):57-67.
Chu C, Pollock LC, Selwyn PA. HIV-associated complications: a systems-based approach. Am Fam Physician. 2017;96(3):161-9.
Baranoski AS, Harris A, Michaels D, Miciek R, Storer T, Sebastiani P, et al. Relationship between poor physical function, inflammatory markers, and comorbidities in HIV-infected women on antiretroviral therapy. J Womens Health (Larchmt). 2014;23(1):69-76. DOI: http://dx.doi.org/10.1089/jwh.2013.4367
Mariano ER, Navarro F, Sauaia BA, Oliveira Junior MNS, Marques RF. Força muscular e qualidade de vida em idosas. Rev Bras Geriatr Gerontol. 2013;16(4):805-11. DOI: http://dx.doi.org/10.1590/S1809-98232013000400014
Bohannon RW. Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther. 2008;31(1):3-10. DOI: http://dx.doi.org/10.1519/00139143-200831010-00002
Medeiros RCDSC, Medeiros JA, Silva TALD, Andrade RD, Medeiros DC, Araújo JS, et al. Quality of life, socioeconomic and clinical factors, and physical exercise in persons living with HIV/AIDS. Rev Saude Publica. 2017;51:66
Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017;8(3):511-9. DOI: http://dx.doi.org/10.3945/an.116.014506
Garcia A, Fraga GA, Vieira RC Jr, Silva CM, Trombeta JC, Navalta JW, et al. Effects of combined exercise training on immunological, physical and biochemical parameters in individuals with HIV/AIDS. J Sports Sci. 2014;32(8):785-92. DOI: http://dx.doi.org/10.1080/02640414.2013.858177
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
